Westpac Banking Corp’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-44,150
Closed -$1.27M 873
2020
Q1
$1.27M Sell
44,150
-2,900
-6% -$168K 0.02% 541
2019
Q4
$3.4M Sell
47,050
-8,400
-15% -$1.03M 0.04% 452
2019
Q3
$7.78M Sell
55,450
-5,578
-9% -$933K 0.11% 268
2019
Q2
$11.2M Sell
61,028
-6,926
-10% -$1.18M 0.17% 157
2019
Q1
$10.8M Sell
67,954
-14,136
-17% -$2.05M 0.18% 162
2018
Q4
$7.86M Buy
82,090
+917
+1% +$105K 0.13% 208
2018
Q3
$11.5M Sell
81,173
-13,300
-14% -$2.05M 0.2% 147
2018
Q2
$14.8M Buy
94,473
+5,847
+7% +$918K 0.28% 105
2018
Q1
$14.3M Buy
88,626
+16,687
+23% +$2.83M 0.29% 102
2017
Q4
$11.8M Buy
71,939
+29,130
+68% +$2.82M 0.27% 108
2017
Q3
$2.67M Buy
+42,809
New +$3.36M 0.06% 364

Other funds holding SAGE